Indo Borax & Chemicals Ltd
Incorporated in 1980, Indo Borax & Chemicals Ltd is in the business of manufacturing Boron and Lithium products[1]
- Market Cap ₹ 1,179 Cr.
- Current Price ₹ 367
- High / Low ₹ 371 / 189
- Stock P/E 27.8
- Book Value ₹ 120
- Dividend Yield 0.27 %
- ROCE 15.5 %
- ROE 11.8 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Debtor days have improved from 25.5 to 17.6 days.
Cons
- Promoter holding has decreased over last quarter: -20.0%
- The company has delivered a poor sales growth of 8.37% over past five years.
- Promoter holding is low: 30.8%
- Company has a low return on equity of 12.8% over last 3 years.
- Promoters have pledged 100% of their holding.
- Earnings include an other income of Rs.24.9 Cr.
- Dividend payout has been low at 5.34% of profits over last 3 years
- Working capital days have increased from 212 days to 479 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 73 | 65 | 67 | 97 | 128 | 115 | 144 | 175 | 215 | 191 | 175 | 215 | |
| 57 | 53 | 56 | 79 | 108 | 97 | 100 | 128 | 153 | 149 | 129 | 171 | |
| Operating Profit | 16 | 12 | 10 | 17 | 20 | 19 | 44 | 48 | 62 | 43 | 46 | 44 |
| OPM % | 21% | 18% | 16% | 18% | 16% | 16% | 31% | 27% | 29% | 22% | 26% | 20% |
| 4 | 3 | 3 | 4 | 5 | 5 | 4 | 3 | 8 | 11 | 15 | 25 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 |
| Profit before tax | 18 | 14 | 12 | 20 | 24 | 23 | 47 | 50 | 69 | 51 | 58 | 66 |
| Tax % | 32% | 32% | 30% | 35% | 27% | 23% | 26% | 27% | 26% | 25% | 28% | 24% |
| 12 | 9 | 8 | 13 | 18 | 18 | 35 | 36 | 50 | 38 | 42 | 50 | |
| EPS in Rs | 3.87 | 2.85 | 2.59 | 4.09 | 5.48 | 5.46 | 10.82 | 11.31 | 15.70 | 11.97 | 13.05 | 15.50 |
| Dividend Payout % | 4% | 5% | 6% | 4% | 3% | 4% | 9% | 1% | 6% | 8% | 8% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 8% |
| 3 Years: | 0% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 4% |
| 3 Years: | -4% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 23% |
| 3 Years: | 44% |
| 1 Year: | 87% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 74 | 83 | 91 | 100 | 117 | 135 | 170 | 204 | 252 | 289 | 331 | 381 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 8 | 8 | 9 | 12 | 11 | 10 | 17 | 14 | 20 | 18 | 21 | 17 | |
| Total Liabilities | 85 | 94 | 103 | 116 | 131 | 148 | 190 | 222 | 275 | 310 | 355 | 403 |
| 11 | 20 | 52 | 51 | 50 | 46 | 89 | 91 | 96 | 99 | 101 | 48 | |
| CWIP | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Investments | 15 | 33 | 24 | 21 | 38 | 19 | 41 | 14 | 19 | 53 | 67 | 207 |
| 58 | 39 | 26 | 43 | 42 | 83 | 59 | 116 | 158 | 157 | 186 | 147 | |
| Total Assets | 85 | 94 | 103 | 116 | 131 | 148 | 190 | 222 | 275 | 310 | 355 | 403 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7 | 12 | 20 | -2 | 15 | 13 | 26 | 11 | 51 | 70 | -61 | 76 | |
| 22 | -23 | -24 | 5 | -16 | 26 | -63 | 26 | -8 | -31 | -8 | -65 | |
| -2 | -1 | -0 | -1 | -1 | -0 | -1 | -3 | -3 | -3 | -3 | -3 | |
| Net Cash Flow | 14 | -12 | -4 | 3 | -2 | 39 | -38 | 34 | 39 | 36 | -72 | 7 |
| Free Cash Flow | -17 | 1 | 18 | -2 | 14 | 13 | 25 | 11 | 46 | 65 | -68 | 95 |
| CFO/OP | -4% | 141% | 217% | 22% | 111% | 100% | 83% | 53% | 107% | 197% | -99% | 216% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 17 | 30 | 28 | 33 | 27 | 25 | 22 | 21 | 22 | 26 | 33 | 18 |
| Inventory Days | 237 | 205 | 38 | 62 | 53 | 56 | 117 | 262 | 215 | 80 | 210 | 102 |
| Days Payable | 40 | 41 | 34 | 20 | 9 | 15 | 31 | 23 | 13 | 13 | 24 | 10 |
| Cash Conversion Cycle | 214 | 195 | 31 | 75 | 71 | 66 | 108 | 260 | 224 | 93 | 218 | 110 |
| Working Capital Days | 121 | 108 | 29 | 77 | 66 | 39 | 56 | 123 | 100 | 47 | 111 | 479 |
| ROCE % | 25% | 17% | 13% | 20% | 22% | 17% | 30% | 26% | 29% | 18% | 18% | 15% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees count |
|
||||||||||
| Trade Receivables Turnover ratio |
|||||||||||
| Installed Capacity - Boron Products MTPA |
|||||||||||
| Production Growth - Boron Products % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2d - Transcript of the Investor/Analyst Earnings Call held on Tuesday, June 2, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
2 Jun - Audio recording of 04FY26 earnings call for audited FY26 results posted on company website.
- Announcement under Regulation 30 (LODR)-Investor Presentation 28 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
28 May - Submitted annual secretarial compliance report for FY2026; no non-compliances or adverse observations reported.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27 May - Earning call with the Analysts/Investors on the Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and year ended March 31, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Jun 2026Transcript PPT REC
Change in Ownership[1]
Company informed that the share purchase transaction under the SPA has been completed on January 23, 2026, wherein the existing promoter group (Jain family) transferred 1.63 crore equity shares representing ~50.8% stake to the acquirers including Zenrock Chemicals Pvt. Ltd., India Special Assets Fund III and Special Situation India Fund, resulting in a change in control and exit of the erstwhile promoters from the company’s shareholding.